March 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for rabeprazole sodium 20-mg delayed-release tablets and ranitidine HCl 15-mg/mL oral ...

(HealthDay)—The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said ...

HealthDay News — The FDA has approved the first generic versions of the gastroesophageal reflux disease (GERD) drug Aciphex (rabeprazole sodium) for people aged 12 and older, the agency has announced.

TOKYO A United States appeals court ruled Monday to block generic competition to Tokyo-based Eisai’s stomach ulcer drug Aciphex. The U.S. Court of Appeals for the Federal Circuit ruled against Teva ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Aciphex (rabeprazole sodium; Eisai) delayed-release tablets for the treatment of gastroesophageal reflux disease ...

The FDA has approved Aciphex (rabeprazole sodium, from Eisai) for the short-term treatment of gastroesophageal reflux disease (GERD) in adolescents ≥12 years of age. In a 12-week study, Aciphex was ...

WOODCLIFF LAKE, N.J. The Food and Drug Administration has approved Aciphex for treatment of gastroesophageal reflux disease in adolescents age 12 and older, Tokyo-based Eisai’s North America ...

Japan’s Eisai says that US regulators have granted a priority review for a new application of the firm’s proton pump inhibitor Aciphex. Japan’s Eisai says that US regulators have granted a priority ...

SAN FRANCISCO (MarketWatch) -- Dr. Reddy's Laboratories Inc. shares fell 7.8% to $15.76 in Monday morning trade. Late Friday, a federal judge ruled that Dr. Reddy's and Teva Pharmaceutical Industries ...

NEW YORK, May 11 (Reuters) - A U.S. court on Friday upheld drug companies seeking to sell cheap versions of the medicine. The court decision was a major victory for Japan-based Eisai, which derives ...